Health regulators have criticized Jeremy Hunt for cutting down the number of NHS walk-in centers. Since 2010, one in every four centers was terminated, even with a hit by patients.
Another study found that one-fourth of all midwives could give up their job in the coming year. This will be because of their complaints regarding poor pay and conditions. The number of walk-in centers in England has decreased to 185 from 238.
It is also revealed that the weak and young patients are not getting proper care as they already are facing problems in meeting their family doctor.
Shadow Health Secretary Andy Burnham said, "NHS walk-in centers are popular with patients and an important means of relieving pressure on A&E".
As per the survey conducted by the Royal College of Midwives, it was found that staff was discouraged and burnt-out.
About 36% of the total of 1,025 midwives revealed they frequently think of parting from their NHS trust. About 24% were so disappointed by the job that they would shift from careers within a year.
Health Minister Lord Howe said they are working to make sure all the services are as per the local requirements and has also agreed to fund £3.8billion to assist health and care services.
On Tuesday, HTC released a statement to announce the launch of a $100 million fund, Vive X. The fund has been designed with the key objective of promoting the growth of startups focused on virtual reality (VR) across the world.
According...
A new study by the Massachusetts Institute of Technology (MIT) has revealed that Istanbul lies...
The Michael J Fox Foundation is aiming to test wearable sensors in smart watches made by Intel's...
China's Dakang Australia has been looking forward to sign a deal to buy Kidman, one of the Australia's biggest beef producers and owner of farm assets. However, the deal could be cancelled as the Australian government said it found that selling...
In January, trade surplus of Germany decreased since plunge in imports was more than a drop in...
Tech giant Google has revealed in a recent announcement that its latest Nik Collection of photo...
German drugmaker Merck said that its experimental cancer medicine evofosfamidehas failed in the last stage of clinical tests due to which it won't seek regulatory approval for its treatment.
On Monday, Darmstadt, Germany-based Merck said...
At the PAX East event this weekend, Harmonix laid down...
A new first-person shooter game was announced by Doom...
In a recent announcement, Amazon has revealed that it...
Sirin Labs, a 2013-founded stealth Israeli startup, has...
© 2011 AustrianTribune - Tribune Online Services. All times CET (GMT + 1.00).